L Meng, J Zha, B Zhou, L Cao, C Jiang, Y Zhu… - PLoS …, 2023 - journals.plos.org
Neutralizing antibodies (nAbs) are important assets to fight COVID-19, but most existing
nAbs lose the activities against Omicron subvariants. Here, we report a human monoclonal …